Page last updated: 2024-08-21

thiazoles and Shock, Cardiogenic

thiazoles has been researched along with Shock, Cardiogenic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böhm, M; Braun-Dullaeus, RC; de Waha, S; Desch, S; Ebelt, H; Eitel, I; Empen, K; Figulla, HR; Fuernau, G; Hambrecht, R; Hausleiter, J; Hennersdorf, M; Kurowski, V; Lauer, B; Maier, SK; Minden, HH; Möllmann, H; Neumann, FJ; Olbrich, HG; Rochor, K; Schneider, S; Schuler, G; Schwarz, B; Strasser, RH; Thiele, H; Werdan, K; Zeymer, U	1
Diéguez, G; Fernández, N; García, AG; García, JL; López, MG	1
Buckley, HT; Harrison, DC; Strosberg, AM	1

Trials

1 trial(s) available for thiazoles and Shock, Cardiogenic

Article	Year
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. American heart journal, 2012, Volume: 163, Issue:6 Topics: Coronary Artery Bypass; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Prognosis; Prospective Studies; Research Design; Shock, Cardiogenic; Thiazoles	2012

Article

Year

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

American heart journal, 2012, Volume: 163, Issue:6

Topics: Coronary Artery Bypass; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Prognosis; Prospective Studies; Research Design; Shock, Cardiogenic; Thiazoles

2012

Other Studies

2 other study(ies) available for thiazoles and Shock, Cardiogenic

Article	Year
PCA50941, a new 1,4-dihydropyridine, reverses endothelin-induced cardiogenic shock in the anesthetized goat. Life sciences, 1998, Volume: 62, Issue:21 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Agonists; Coronary Circulation; Dihydropyridines; Endothelin-1; Female; Goats; Heart; Heart Rate; Infusions, Intravenous; Shock, Cardiogenic; Thiazoles; Ventricular Function, Left	1998
Circulatory effects of tazolol in experimental myocardial infarction. The American journal of cardiology, 1975, Volume: 35, Issue:5 Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiac Output; Dogs; Drug Evaluation; Heart Rate; Hemodynamics; Infusions, Parenteral; Isoproterenol; Propanolamines; Shock, Cardiogenic; Thiazoles; Time Factors; Vascular Resistance	1975

Article

Year

PCA50941, a new 1,4-dihydropyridine, reverses endothelin-induced cardiogenic shock in the anesthetized goat.

Life sciences, 1998, Volume: 62, Issue:21

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Agonists; Coronary Circulation; Dihydropyridines; Endothelin-1; Female; Goats; Heart; Heart Rate; Infusions, Intravenous; Shock, Cardiogenic; Thiazoles; Ventricular Function, Left

1998

Circulatory effects of tazolol in experimental myocardial infarction.

The American journal of cardiology, 1975, Volume: 35, Issue:5

Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiac Output; Dogs; Drug Evaluation; Heart Rate; Hemodynamics; Infusions, Parenteral; Isoproterenol; Propanolamines; Shock, Cardiogenic; Thiazoles; Time Factors; Vascular Resistance

1975